Search results
A former Amazon employee is trying to manage his lupus nephritis without insurance. He doesn't miss...
INSIDER via Yahoo News· 1 year agoJordan Flowers.Courtesy of Jordan Flowers Jordan Flowers was terminated while pushing for...
Aurinia (AUPH) Up 11% on Issue of New Additional Lupkynis Patent
Zacks via Yahoo Finance· 1 year agoAurinia Pharmaceuticals (AUPH) announces the issue of its new and refined method-of-use patent,...
Toni Braxton's Life-Saving Advice for People Living With Lupus
The Root via Yahoo News· 8 months agoNearly 1.5 million Americans live with lupus, a chronic disease in which the immune system attacks...
Toni Braxton's Favorite Snack May Already Be in Your Freezer
Eating Well via Yahoo News· 7 months agoPlus, the comfy walking shoes she loves and how she’s bringing awareness to lupus. Gonzalo...
Why Top 1% Biotech Stock Nkarta Just Plummeted, Undercutting Its 50-Day Line
Investor's Business Daily· 2 months agoTop-notch Nkarta stock tumbled Friday after the biotech company deprioritized a cancer drug in favor...
Aurinia's (AUPH) Oral Lupus Drug Lupkynis Gets European Approval
Zacks via Yahoo Finance· 2 years agoAurinia Pharmaceutical (AUPH) receives marketing authorization from the European Union for its...
Why Kezar Life Sciences Stock Is Crushing It Today
Motley Fool· 2 years agoShares of the clinical-stage biotech Kezar Life Sciences (NASDAQ: KZR) are soaring this morning following a positive mid-stage data readout for its lupus...
GSK says U.S. FDA approves kidney disease drug for children
Reuters via Yahoo News· 2 years agoThe clearance makes Benlysta the first treatment approved by the U.S. regulator for children with...
Aurinia (AUPH) Up on Paving the Way for a Potential Buyout
Zacks via Yahoo Finance· 10 months agoAurinia Pharmaceuticals AUPH rose almost 5.8% on Jun 30, as management announced that it is...
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoAurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2022 Earnings Call Transcript February 28, 2023...